Jones Trading Downgrades Silverback Therapeutics (SBTX) to Hold
Tweet
Share
E-mailGet Alerts SBTX Hot Sheet
Price: $5.87 --0%
Rating Summary:
0 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
0 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Jones Trading analyst Soumit Roy downgraded Silverback Therapeutics (NASDAQ: SBTX) from Buy to Hold.
For an analyst ratings summary and ratings history on Silverback Therapeutics click here. For more ratings news on Silverback Therapeutics click here.
Shares of Silverback Therapeutics closed at $3.51 yesterday.
You May Also Be Interested In
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- Deutsche Bank Downgrades Shurgard Self Storage SA (SHUR:BB) to Hold
- UBS Downgrades Alsea SAB de CV (ALSEA:MM) (ALSSF) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
